棕色海藻寡糖在肥胖和便秘管理方面的影响
Jingyu Gao1,2,3, Fan Wu1,2,3, Mingzhu Yan4
1College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
棕色海藻寡糖化物 (BSO) 在治疗肥胖和便秘方面表现有前途. 研究表明,BSO有效地减少体重增加,改善血液脂质,增强肠道健康.
科学领域:
- 营养科学 营养科学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 棕色海藻寡糖 (BSO) 已被认为具有潜在的健康益处,包括降低胆固醇,抗肥胖和抗便秘作用.
- 肥胖和便秘是普遍存在的健康问题,具有重大临床和经济影响.
研究的目的:
- 在高脂肪饮食诱导的老鼠肥胖模型中研究BSO对体重,血脂和脂肪组织的影响.
- 为了评估BSO在loperamide化物诱导的便秘小鼠模型中的预防性疗效,评估胃肠功能.
主要方法:
- 给老鼠食高脂肪饮食以诱导肥胖,然后给BSO以评估代谢和脂肪组织变化.
- 给小鼠服用洛佩拉米德化物来诱导便秘,并分析了BSO对排便和肠道通行的影响.
主要成果:
- 在肥胖大鼠中,BSO的使用显著降低了体重增加,改善了血液脂质概况,降低了内脏脂肪.
- 在便秘模型中,BSO干预显著增加了便产量和水含量,并增强了肠道过渡.
结论:
- BSO在减轻与肥胖相关的代谢功能障碍和缓解便秘方面表现出显著的有效性.
- 这些发现支持BSO作为临床应用的安全有效营养药的潜力,用于控制肥胖和便秘.
更多相关视频
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
